The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global mobile imaging services market was valued at US$ 13.54 Billion in 2021.
We expect the global mobile imaging services market to exhibit a CAGR of 6.80% during 2022-2027.
The high prevalence of several chronic diseases, along with the growing prominence of mobile imaging services for offering higher efficiency, enhanced patient care quality, faster diagnosis, etc., is currently driving the global mobile imaging services market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of mobile
imaging technology to detect and monitor disease progression in coronavirus-infected patients.
Additionally, this technology facilitates remote data storage and patient history tracking.
Based on the product type, the global mobile imaging services market can be categorized into X-ray,
CT, ultrasound, MRI, mammography, nuclear imaging, and others. Among these, X-ray holds the
majority of the total market share.
Based on the patient type, the global mobile imaging services market has been segmented into adult
and pediatrics. Currently, adult patients represent the largest market share.
Based on the end user, the global mobile imaging services market can be bifurcated into hospitals and clinics, home healthcare, and others. Among these, hospitals and clinics currently account for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global mobile imaging services market include Accurate Imaging
Inc., Atlantic Medical Imaging, Cobalt Health, DMS Health Technologies Inc., Front Range Mobile
Imaging Inc., InHealth Group, Interim Diagnostic Imaging LLC, Nuffield Health, RadNet Inc., Shared
Medical Services, and TridentCare LLC.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at